119. Has the Federal government covered half the hospital costs for people in hospital with Covid? Was this money reimbursed to State governments? If so, doesnt this create an incentive for State government to fudge Covid cases in hospital in order to milk the Federal government of Funding? 120. Does the Federal government reimbursing states such as NSW for back capturing whereby that State government counts people as having Covid, even if they had it 28 days prior to entering hospital and went to hospital for another reason such as a broken arm?
Question Number: 303PDR Number: SQ22-000679Date Submitted: 21/11/2022Department or Body: Department of Health Under the National Partnership on COVID-19 Response (Partnership) Hospital Services Payment, the Australian Government provides a 50% contribution to the states and territories (jurisdictions), for the diagnosis and treatment of COVID-19, including suspected cases. All funding provided to jurisdictions under the Partnership is […]
147. I note that the TGA relied on clinical study 4591001 to determine the safety of booster shots yet this study only examined the impact of 2 shots. Wasn’t it reckless of the TGA to approve the rollout of a third shot with no adequate trial studies of three shots?
Question Number: 278PDR Number: SQ22-000649Date Submitted: 21/11/2022Department or Body: Department of Health The Therapeutic Goods Administration (TGA) has provisionally approved booster doses of the Pfizer COVID-19 vaccine, COMIRNATY, in individuals aged five years and older. The safety and efficacy of this booster dose was demonstrated in clinical study C4591001, in which individuals who had previously […]
145. What is the optimal amount of intact mRNA for the vaccine to be effective?
Question Number: 277PDR Number: SQ22-000648Date Submitted: 21/11/2022Department or Body: Department of Health The approved dosages, including active ingredients (amount of mRNA) for each provisionally approved mRNA vaccine (Pfizers COMIRNATY and Modernas SPIKEVAX) for each age group can be found in the Product Information (PI) document for each COVID-19 vaccine. PIs are available on the TGAs […]
244. Why did the TGA approve molnupiravir despite the fact there were concerns that the drug may cause cancer mutations? It is known in medicine that mutation of a single base is sufficient to cause disease, sickle cell anaemia being one example. – https://quadrant.org.au/opinion/public-health/2022/08/the-suppression-of-usefulcovid-19-treatments/ 261. Until recently patients presenting with anti-bodies to their thyroids have had it stated on their blood results that the antibody pattern suggests an underlying autoimmune inflammatory process e.g. Graves and Hashimotos. The way to examine these results was changed on 06/09/21 and the reference interval was updated. Why has the reference interval been updated/changed and is it true that Medicare requested QML that such wording be removed from patients written test results?
Question Number: 275PDR Number: SQ22-000646Date Submitted: 21/11/2022Department or Body: Department of Health Question 244 Quadrant magazine is not a reputable medical journal. Even though the decision to provisionally approve molnupiravir was made on the basis of short-term efficacy and safety data, the data submitted to support the quality, safety and efficacy of molnupiravir was comprehensively […]
142. Why did Pfizer set the specification settings for the vaccine and not the TGA i.e. percentage of intact mRNA?
Question Number: 274PDR Number: SQ22-000645Date Submitted: 21/11/2022Department or Body: Department of Health It is not clear what specification settings are being referred to. While Pfizer did specify the proposed primary efficacy outcomes of the clinical trials, this is the usual practice for any organisation public sector or private sector sponsoring clinical trials. […]
185. Studies have shown that neutrophils interact with spike proteins to create fibrils that lead to amyloids clots. Has the TGA examined this risk, and can they guarantee that amyloid clots arent being formed by the vaccine? 190. I note that the Europeans Medicine Agency has added heavy menstrual bleeding as a side effect of Pfizer and Moderna Covid jabs. Given this delayed warning what testing will the TGA do to ensure that the heavy bleeding isn’t the result of clots and that women are not at danger of having their fertility damaged?
Question Number: 272PDR Number: SQ22-000643Date Submitted: 21/11/2022Department or Body: Department of Health Question 185 An in vitro study showed that the spike protein mixed in a test tube with neutrophil elastase formed amyloid-like fibrils, which might cause blood clots. However, there is no evidence of the spike protein from COVID-19 mRNA vaccines causing blood clots […]
143. Is there evidence that demonstrates that three potentially ineffective stop codons are any better than one. A leaky bucket is a leaky bucket is it not? Can data please be provided to prove that Methylpseudouridine is just as effective as uridine in stopping codon read through?
Question Number: 271PDR Number: SQ22-000642Date Submitted: 21/11/2022Department or Body: Department of Health Yes – methylpseudouridine is as effective as uridine in stopping codon read through. It is reported in the literature that methylpseudouridine enhances RNA stability and decreases anti-RNA immune response. It is also reported that fully modified RNAs (U substituted with N1-methylpseudouridine) are likely […]
146. Why doesn’t the TGA have mandatory reporting requirements of Health professionals for reporting adverse events? Shouldn’t it be mandatory given that the vaccines have only received provisional approval and data from ongoing trials are being assessed on an outgoing basis? 148. In the Post marketing surveillance data there is over 1,000 adverse events of interest – what exactly are adverse events of interest – are they reported adverse events? 149. If the current vaccines fall outside many of the international guidelines for testing vaccines, then isn’t it fair to say they aren’t vaccines. 150. In the post marketing surveillance data – what was the total population of the administered doses? I note this figure has been censored by Pfizer and the FDA – why is such an important indicator of safety being covered up and why won’t the TGA ask for that number and then disclose it? 151. Why did the TGA change death description to Adverse Event following immunisation to avoid scrutiny over cause of death regarding a number of young children were reported to have died from the vaccine?
Question Number: 270PDR Number: SQ22-000641Date Submitted: 21/11/2022Department or Body: Department of Health Question 146 This question has been previously addressed see SQ21-001214 (Q115). To implement mandatory reporting would require parliament to pass changes to the Therapeutic Goods Act 1989. Question 148 Adverse Events of Special Interest (AESI) are defined as a pre-specified medically-significant event […]
227. The virus needs two enzymes to cross the membrane whereas the vaccine needs none as it relies in transfection – is that correct? If that is the case, then is it fair to say the vaccine is more infectious, isn’t it? 286. Aren’t nasal sprays better than vaccines for respiratory viruses that enter through the airways? 287. What steps or tests has the health department taken to ensure that immune imprinting or antibody dependent enhancement is not occurring with repeated booster shots. This is a well-known phenomenon, dengue fever being a prime example. It was highlighted by Pfizer as a potential risk. Furthermore, why isn’t this potential risk highlighted in any Covid booster advertising? 290. Is the overuse of booster and the use of a stronger spike protein causing the immune system to downregulate in other areas leading to cancer and diabetes?
Question Number: 269 PDR Number: SQ22-000640 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 227 The vaccine mRNA encapsulated in lipid nanoparticles (LNPs) enters into cells without the assistance of enzymes. The COVID-19 vaccines are designed to trigger immunity against SARS-CoV-2 virus. The vaccines are not infectious themselves given that the spike proteins […]
51. The molecular weight of the SARS-CoV-2 encoded protein ranges from 135-200 kilodaltons depending on the extent of glycosylation. Does this proof that the margin of error in trying to get the body to produce a protein safely is too high? In vitro Characterization of SARS-CoV-2 Protein Translated from the Moderna mRNA-1273 Vaccine (medrxiv.org) 285. How did the Furin gene get into the Sars-Cov- 2 virus given it was never in a previous Coronavirus?
Question Number: 268 PDR Number: SQ22-000639 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 51 The Senator has referred to a manuscript which is a preliminary report of work that has not been certified by peer review. However, many proteins, including antibodies exhibit variable levels of glycosylation with no impact on safety or […]
